IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,236,800 | +52.8% | 380,000 | +38.2% | 0.07% | -17.1% |
| Q2 2023 | $11,283,250 | -48.4% | 275,000 | -55.0% | 0.08% | -13.7% |
| Q1 2023 | $21,858,584 | +157.2% | 611,600 | +171.8% | 0.10% | +9.2% |
| Q4 2022 | $8,498,250 | -3.8% | 225,000 | +12.6% | 0.09% | +11.5% |
| Q3 2022 | $8,837,000 | +6.1% | 199,800 | -11.2% | 0.08% | +23.8% |
| Q2 2022 | $8,330,000 | -10.0% | 225,000 | -10.0% | 0.06% | -49.6% |
| Q1 2022 | $9,260,000 | -0.2% | 250,000 | -18.0% | 0.12% | +33.0% |
| Q4 2021 | $9,281,000 | +4.4% | 305,000 | +15.1% | 0.09% | -22.3% |
| Q3 2021 | $8,888,000 | +20.4% | 265,000 | +43.2% | 0.12% | +36.0% |
| Q2 2021 | $7,380,000 | +25.9% | 185,000 | +41.9% | 0.09% | +23.6% |
| Q1 2021 | $5,863,000 | -67.6% | 130,400 | -59.2% | 0.07% | -25.8% |
| Q4 2020 | $18,092,000 | +205.0% | 320,000 | +156.0% | 0.10% | +10.2% |
| Q3 2020 | $5,931,000 | -28.1% | 125,000 | -10.7% | 0.09% | -38.9% |
| Q2 2020 | $8,254,000 | +287.9% | 140,000 | +211.1% | 0.14% | +171.7% |
| Q1 2020 | $2,128,000 | +17.4% | 45,000 | +50.0% | 0.05% | +32.5% |
| Q4 2019 | $1,812,000 | -12.2% | 30,000 | -25.0% | 0.04% | +53.8% |
| Q3 2018 | $2,063,000 | -55.0% | 40,000 | -63.6% | 0.03% | -59.4% |
| Q2 2018 | $4,584,000 | +73.3% | 110,000 | +83.3% | 0.06% | +16.4% |
| Q1 2018 | $2,645,000 | – | 60,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |